Clinical Trial

Clinical Outcomes of Patients With Coronary Artery Disease

Study acronym: COCAD
Recruiting
View on ClinicalTrials.gov →
Summary
Coronary heart disease (CHD) stands as a foremost contributor to global mortality, characterized by complex pathogenesis that renders conventional "one-size-fits-all" preventive strategies inefficient. Therefore, the investigators designed a prospective, multi-center cohort study among patients hospitalized due to either confirmed or suspected CHD, which aimed to establish a holographic data set for the diagnosis and treatment of CHD and explore the impact of critical therapeutic strategies in the real world on the clinical outcomes of CHD patients, providing evidence to optimize the management pathway.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-11; most recent amendment 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2025-09-03
Trial Details
NCT Number NCT06216847
Lead Sponsor Shenyang Northern Hospital
Conditions Coronary Heart Disease (CHD)
Enrollment 10,000 participants
Start Date 2024-02-21
Primary Completion 2026-10-31 (estimated)
Study Completion 2030-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-10